Comprehensive telomere‑based liquid biopsy platform offering AI‑powered quantitative 3D telomere analysis to detect disease‑associated genomic instability for prognostic and diagnostic use in oncology and neurological diseases. Targets pathologists, clinicians, academic researchers and drug developers with simple, accurate, non‑invasive tests, including a lead prognostic assay for Multiple Myeloma.